Acute Myeloid Leukemia subtype classification using single blood cell images.
Acute Myeloid Leukemia (AML) is a heterogeneous cancer that affects the myeloid lineage of blood cells.
APA
Chainani R, Vimala R, et al. (2025). Acute Myeloid Leukemia subtype classification using single blood cell images.. Discover oncology, 17(1), 85. https://doi.org/10.1007/s12672-025-04206-3
MLA
Chainani R, et al.. "Acute Myeloid Leukemia subtype classification using single blood cell images.." Discover oncology, vol. 17, no. 1, 2025, pp. 85.
PMID
41364141
Abstract
Acute Myeloid Leukemia (AML) is a heterogeneous cancer that affects the myeloid lineage of blood cells. It requires accurate subtype identification for effective treatment. This study proposes a novel framework for AML detection and subtype classification using a two-step classification strategy: an initial classifier, trained on a dataset of single-cell peripheral blood smear images, categorizes individual cell images according to their cell type, followed by a model that utilizes these predictions to detect the presence of AML and determine the subtype. The methodology incorporates custom-trained CNNs and conventional machine learning algorithms to build an "ensemble of ensembles" which has been unified through a soft voting mechanism to enhance classification robustness. To address domain shift and variability in staining and contrast across datasets, cross-dataset validation and a robust preprocessing pipeline involving stain normalization and brightness correction have been tested and implemented. Additionally, Multiple Instance Learning and pseudo-labeling paradigms have been explored to compare their performance with the proposed methodology, which has demonstrated promising results and offers a practical foundation for further development in image-based AML subtype identification. The single cell classifier achieved 94.7% accuracy, 95.2% precision, and a 94.8% F1-score and our proposed ensemble model achieved 94% accuracy when distinguishing between healthy patients from AML patients.